Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

DECEMBER 9, 2021

08, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. He was the London Stroke Clinical Director from 2010-2019 and the National Clinical Director for Stroke for NHS England from 2013-2019, where he oversaw dramatic improvements in the paradigm of NHS stroke treatment. Moreau CEO of Algernon Pharmaceuticals Inc. “We

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

The Cannigma

SEPTEMBER 21, 2021

There are cannabis users, patients, and just everyday fans who may be fans, but don’t make it a big part of their public persona. For these famous medical cannabis patients and supporters, it is something that can improve quality of life and which should be made readily available to anyone in need. 1) Patrick Stewart. It’s tricky.”.

Patients 94

Patients Research and Development Sleep Clinical Trials 94

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. September 23, 2019. What about other medical cannabis products? PDF Version.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Life Network

OCTOBER 8, 2019

Dissolve Strips ™ (sublingual cannabis wafers) Now Available to Aurora’s Canadian Medical Patients NYSE | TSX: ACB OTC: CTTH EDMONTON and HAMILTON, ON, Oct. The post Aurora Cannabis and CTT Pharmaceutical Launch Sublingual Cannabis Wafers appeared first on Cannabis News | Lifestyle Tips | Expert Opinions | Stocks.

Pharmaceutical 40

Pharmaceutical Cannabis Patients Business 40

NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”

Law 257

Law Patients Access Oil 257

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. 30 May 2019. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

CannaTech

JANUARY 16, 2019

Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. Of course, patients need product and product costs money.

Access 89

Access Patients Pharmaceutical Education 89

Veriheal

FEBRUARY 11, 2021

The National Institute on Drug Abuse stated that more than 70,000 American lives were claimed by opioid prescription drugs in 2019 alone! They conducted an online survey of patients from three medical practice sites. Many Patients Decreased or Completely Stopped Opioid Medication.

Chronic Pain 85

Chronic Pain Patients Clinical Trials Treatment 85

Cannabis Law Report

JULY 19, 2019

July 18, 2019 (GLOBE NEWSWIRE) — ICC International Cannabis Corp. Under the terms of the Agreement, ICC will supply NUBU will a suite of full-spectrum pharmaceutical grade medical cannabis products including: Packaged and labelled medical cannabis including; oil/tincture and capsules in finished goods form. CSE: WRLD.U)(FWB:

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

Cannabis Law Report

DECEMBER 30, 2019

This report contains a detailed summary of 2019’s federal and state legislative victories.” 2019 has been an unprecedented year for the passage of state-level marijuana law reforms. “Never before in American history has marijuana policy advanced in Congress as far or as fast in one year as 2019.

Legislation 59

Legislation Patients Access Banking 59

Cannabis Law Report

JULY 21, 2019

FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”). (CSE: WRLD.U)(FWB:

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

Cannabis Law Report

JULY 23, 2019

(TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). This EU pharmaceutical entity is an optimal addition to LGC. LGC’s investment will build on this growth mom.

Pharmaceutical 45

Pharmaceutical Seed-To-Sale Compliance Compliance 45

Cannabis Law Report

JANUARY 5, 2022

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc. 2 Goates et al. Robert Schatz.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Project CBD

SEPTEMBER 12, 2023

Medicine in a Can A total of 15 patients with different incurable ailments would enroll in the Compassionate IND Program to study cannabis before it was officially shut down in 1992. He would undergo a dozen surgeries and consume a steady diet of prescription narcotics and other pharmaceuticals.

Chronic Pain 228

Chronic Pain Treatment Cannabinoids Research and Development 228

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Veriheal

JUNE 29, 2021

The Right to Try Act or the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act was signed into law on May 30th, 2019, according to the US Food and Drug Administration. A Push by Patients. The lawsuit states the therapeutic potential of not just psilocybin but also of MDMA for cancer patients.

Therapy 55

Therapy DEA Patients Clinical Trials 55

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. An estimated 250 patients a month are said to be prescribed cannabis medicines through the NHS compared to over 2,500 in the UK’s private sector. Step In Right Direction.

Data 52

Data Patients Clinical Trials Business 52

Cannabis Law Report

JUNE 7, 2021

The Phase 1 clinical trial on Alzheimer’s patients is currently anticipated to conclude during the July through September 2021 timeframe. A Phase 1 clinical trial is the first step of a human clinical trial in a multi-step process designed to obtain regulatory approval for the marketing of a new pharmaceutical drug.

Clinical Trials 105

Clinical Trials Patients THC Safety 105

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

The Blunt Truth

OCTOBER 3, 2019

They maintain that the limits will put constraints on the amount of marijuana available to patients. GW Pharmaceuticals and Montefiore Medical Center in New York are teaming up to study the use of a cannabis compound on autism. Also in New Mexico , growers of medical cannabis are suing the state over limits on plant-count.

Chronic Pain 77

Chronic Pain Hemp DEA Programs 77

NORML

JANUARY 24, 2019

It seeks to redefine allowed dosage limitations and formulations, and expand patient access and reduce patient cost by adding nurse practitioners and physician assistants to the list of those authorized to issue written certifications to patients. Marijuana policy should be evidence based.

Policy 154

Policy Patients Education Legislation 154

Cannabis Law Report

DECEMBER 23, 2019

Posted by Alexa Steinberg, Esq. | Dec 20, 2019 . Here’s a look back at 2019 and a projection of what’s to come in 2020 Cannabis Law. . March 2019 – Development of LA’s Phase 3 Retail License Application. . We saw no movement or resolve with this issue in 2019.

Law 59

Law Banking Hemp Retail 59

Cannabis Law Report

JUNE 22, 2022

Greenlab, based at Lincoln University, is engaged in research, development and cultivation of pharmaceutical grade medical cannabis compounds. It was the first New Zealand South Island based company to be awarded a research and development licence in August 2019, the same year it was founded.

Research and Development 52

Research and Development Pharmaceutical Medicine Cultivation 52

Cannabis Law Report

JUNE 24, 2021

Luxembourg is scrambling to secure a new medical cannabis supplier after encountering delays of up to 60 days, leaving new patients empty-handed. Initially, Aurora supplied the medicines, a Canadian firm that was replaced in 2019 by Canopy Growth-Spectrum Pharmaceutics. Website Delano reports. Complementary therapy.

Medicine 104

Medicine Chronic Pain Treatment Patients 104

Cannabis Law Report

JULY 7, 2022

January 2019. filed a petition requesting inter partes review of claims 1-13 of GW Pharmaceutical Ltd.’s GW Pharma Limited and Otsuka Pharmaceutical Co., BYLINED ARTICLES. Sterne, Kessler, Goldstein & Fox P.L.L.C. Eleven of thirteen cannabis patent claims survive PTAB challenge. Insys Development Company, Inc. 36 (P.T.A.B.

Epilepsy 52

Epilepsy Pharmaceutical Treatment Cannabinoids 52

Cannabis Law Report

SEPTEMBER 12, 2019

11, 2019 /PRNewswire/ – Aurora Cannabis Inc. the “ Company ” or “ Aurora “) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today its financial and operational results for the fourth quarter and fiscal year ended June 30, 2019. million in Q3 2019.

Research and Development 45

Research and Development Extraction Cannabis Wellness and Beauty 45

Veriheal

SEPTEMBER 27, 2021

The society launched a campaign with the hashtag #ApprovedButDenied protesting the difficulty so many patients have faced attempting to obtain medical cannabis. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? ApprovedButDenied.

Treatment 98

Treatment Patients Access Research and Development 98

NORML

JUNE 13, 2019

Millions of Americans are legally replacing pharmaceuticals with cannabis and the question of affordability has become critical. Price caps that could favor seriously ill patients/consumers will be an entirely new concept to the cannabis industry, but it’s no innovation. Are you paying too much for medical marijuana?

Marijuana 263

Marijuana Dispensary Patients Cannabinoids 263

NewsMunchies

DECEMBER 13, 2021

In the largest clinical trial to date, a new study conducted by the UK-based pharmaceutical company Compass Pathways shows that psilocybin or “magic” mushrooms can safely relieve depression. The trial included 233 patients from 10 countries in North America and Europe. In 2019, Denver became the first city in the U.S.

Clinical Trials 95

Clinical Trials Therapy Decriminalization Patients 95

Project CBD

MARCH 8, 2019

Immediately in response, the FDA announced that CBD is considered a “drug” and is thus subject to pharmaceutical regulations. As of February 2019, the Veterinary Medical Board in California still has no official policy on hemp products. The Evolving Regulatory Status of Cannabidiol.

Pets 215

Pets Legalization Hemp Extraction 215

The Cannigma

FEBRUARY 1, 2023

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. Individuals who use cannabis-based medications often want to cure their cancer, not just reduce the symptoms that come with the condition. The answer: Maybe!

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

The Cannigma

DECEMBER 4, 2022

Another draft law was introduced in 2019 to expand the program; as of 2022, it was still in draft in a chamber of government. Patients can be prescribed medical marijuana in the form of pharmaceuticals, like Sativex. However, this legalization is a technicality, as there is no established medical program for patients to join.

Law 59

Law Seed-To-Sale Programs Tincture 59

Project CBD

SEPTEMBER 12, 2023

Medicine in a Can A total of 15 patients with different incurable ailments would enroll in the Compassionate IND Program to study cannabis before it was officially shut down in 1992. He would undergo a dozen surgeries and consume a steady diet of prescription narcotics and other pharmaceuticals.

Chronic Pain 130

Chronic Pain Treatment Cannabinoids Research and Development 130

Cannabis Law Report

APRIL 28, 2022

High-quality cannabis flowers from DEMECAN’s German high-end facility are now available to patients. DEMECAN is the only independent German cannabis producer supplying patients in Germany with cannabis flowers from its own EU-DEMECAN has established itself as the only independent producer of medical cannabis and leading wholesaler in Germany.

Pharmaceutical 52

Pharmaceutical Cultivation Collective Patients 52

CannaTech

APRIL 1, 2020

When I was at Pharmacy School at Sydney University, more than 20 years ago, we learned the pharmaceutical and clinical sciences ranging from the design, synthesis, formulation, dispensing and testing of drugs and the clinical and social aspects of pharmacy.

Supply Chain 98

Supply Chain Chronic Pain Pharmaceutical Patients 98

Cannabis Law Report

AUGUST 30, 2019

Americans for Safe Access released its 2018-2019 State-of-the-State report examining state laws and regulations surrounding Patient Rights and Civil Protection from Discrimination, Access to Medicine, Ease of Navigation, Functionality of the Programs, and Consumer Safety and Provider Requirements. Medical/Health.

Banking 45

Banking Research and Development Legislation Programs 45